Lean Away From Sunosi for Excessive Daytime Sleepiness

September 2019

Sunosi (suh-NOH-see, solriamfetol) will be a new Rx for excessive daytime sleepiness.

Think of Sunosi as similar to armodafinil (Nuvigil) or modafinil (Provigil). All three are approved to improve wakefulness in adults with obstructive sleep apnea or narcolepsy...and are C-IV meds.

You'll hear Sunosi is "dual-acting" on dopamine and norepinephrine in the brain. Armodafinil and modafinil may work by affecting dopamine.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Vaccines Rethink Prevnar 13 for Healthy Seniors
Hypertension Consider Nuances When Managing Hypertension in Older Adults
Pneumonia Don't Automatically Add Empiric Anaerobic Coverage for Aspiration Pneumonia
ADHD Solve Common Dilemmas With ADHD Stimulants
Scabies Consider Patient Preferences When Treating Scabies
Diabetes Help Patients With Diabetes Decipher Continuous Glucose Monitor Metrics
Sleep Disorders Lean Away From Sunosi for Excessive Daytime Sleepiness
Anticholinergics Look for Opportunities to Limit Anticholinergic Meds in Older Adults
Kidney Disease Emphasize Adherence With Phosphate Binders in Chronic Kidney Disease
Sexual Dysfunction Don't Buy Into the Hype About Vyleesi for Low Sexual Desire in Women
Surgery Assess Perioperative Infection Risk for Immunosuppressants and Biologics

Lean Away From Sunosi for Excessive Daytime Sleepiness

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Table of Contents